• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » National Institute of Mental Health issues strategic plan for research

National Institute of Mental Health issues strategic plan for research

March 26, 2015
CenterWatch Staff

The National Institute of Mental Health (NIMH) has issued a new strategic plan for research. Informed by the successes and challenges of recent years, the new plan updates the strategic objectives of its 2008 predecessor with the aim of balancing the need for long-term investments in basic research with urgent mental health needs.

“A strategic plan can identify the most important problems and identify areas of traction,” said Thomas R. Insel, M.D., NIMH director. “This update of our strategic plan is a commitment to take a fresh look at our horizons so that we can refine priorities and energize our path of discovery.”

According to recent estimates, mental illnesses account for 21.3% of all years lived with disability in the U.S. An estimated 9.6 million American adults suffer from a serious mental illness in which the ability to function in daily life is significantly impaired. Furthermore, over 41,000 Americans died in 2013 from suicide, more than twice the annual mortality from homicide or AIDS. Changing these statistics depends not only on continued effort in areas in which there have been dramatic advances, but in less fully explored areas, such as the mechanisms by which environmental influences alter brain and behavior, as well as in research to improve and broaden access to health care services.

To go forward, the plan has revised the original four high-level strategic objectives as follows:

  1. Define the mechanisms of complex behaviors
  2. Chart mental illness trajectories to determine when, where and how to intervene
  3. Strive for prevention and cures
  4. Strengthen the public health impact of NIMH-supported research.

These four objectives form a broad roadmap for the institute’s research priorities over the next five years, beginning with the fundamental science of the brain and behavior, and ending with public health impact. The overall funding strategy is to pursue long-term objectives by supporting investigator-initiated proposals based on scientific opportunities, while using targeted funding announcements to address near-term goals.

A diverse community of stakeholders helped review and provide comments on the draft update of the plan. These include the National Advisory Mental Health Council and the NIMH Alliance for Research Progress, a gathering of the major foundations and mental health research advocacy groups. A revised draft plan was published for public comment in November; the institute received nearly 600 comments from individuals, groups and organizations, as well as from the National Advisory Mental Health Council.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing